A two-tiered targeted proteomics approach to identify pre-diagnostic biomarkers of colorectal cancer risk
Journal article, 2021

Colorectal cancer prognosis is dependent on stage, and measures to improve early detection are urgently needed. Using prospectively collected plasma samples from the population-based Northern Sweden Health and Disease Study, we evaluated protein biomarkers in relation to colorectal cancer risk. Applying a two-tiered approach, we analyzed 160 proteins in matched sequential samples from 58 incident colorectal cancer case–control pairs. Twenty-one proteins selected from both this discovery phase and the literature were then analyzed in a validation set of 450 case–control pairs. Odds ratios were estimated by conditional logistic regression. LASSO regression and ROC analysis were used for multi-marker analyses. In the main validation analysis, no proteins retained statistical significance. However, exploratory subgroup analyses showed associations between FGF-21 and colon cancer risk (multivariable OR per 1 SD: 1.23 95% CI 1.03–1.47) as well as between PPY and rectal cancer risk (multivariable OR per 1 SD: 1.47 95% CI 1.12–1.92). Adding protein markers to basic risk predictive models increased performance modestly. Our results highlight the challenge of developing biomarkers that are effective in the asymptomatic, prediagnostic window of opportunity for early detection of colorectal cancer. Distinguishing between cancer subtypes may improve prediction accuracy. However, single biomarkers or small panels may not be sufficient for effective precision screening.

Author

Sophia Harlid

Umeå University

Justin Harbs

Umeå University

Robin Myte

Umeå University

Carl Brunius

Chalmers, Biology and Biological Engineering, Food and Nutrition Science

Marc Gunter

International Agency for Research on Cancer (IARC)

Richard Palmqvist

Umeå University

Xijia Liu

Umeå University

B. van Guelpen

Umeå University

Scientific Reports

2045-2322 (ISSN)

Vol. 11 1 5151

Infrastructure

Chalmers Infrastructure for Mass spectrometry

Areas of Advance

Health Engineering

Subject Categories

Urology and Nephrology

Environmental Health and Occupational Health

Cancer and Oncology

DOI

10.1038/s41598-021-83968-6

PubMed

33664295

More information

Latest update

4/1/2021 9